Immunohistochemistry (IHC) has seen significant advancements, enhancing the ability to detect specific antigens in tissues. New antibodies and detection systems have been developed, improving sensitivity and specificity. IHC now plays a crucial role in cancer diagnosis, allowing for the identification of tumor markers and aiding in the development of personalized treatment plans.
